Drug Topics

FEBRUARY 6, 2025

Experts believe a bird flu outbreak is responsible for hundreds of dead birds washing ashore on the beaches of Chicago.

452

452

Pharmacy Times

FEBRUARY 6, 2025

There were no substantial differences for the mindfulness with substance use or anxiety outcomes compared with the recovery control group.

133

133

Drug Topics

FEBRUARY 6, 2025

With the acceptance of the new drug application and granting priority review, the target action date is August 12, 2025.

FDA 282

FDA 282

Fierce Healthcare

FEBRUARY 6, 2025

The storm decimated half a dozen states, killing hundreds and forcing local health systems to contend with the fallout. Some hospitals were well prepared. Others were destroyed. Everyone was doing what they could to figure out contingencies on the fly. This, experts warn, will not be the last time.

Hospitals 131

Hospitals 131

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

Patient Care

Drug Topics

FEBRUARY 6, 2025

In a network meta-analysis, researchers compared the safety and efficacy of available analgesic treatment for treating acute pain in children.

281

281

PharmaVoice

FEBRUARY 6, 2025

The market has been no less demanding for pharma giants as 2025 begins, but last year’s strategies are paying off.

130

130

Fierce Healthcare

FEBRUARY 6, 2025

Managers across the health agencies were tasked with categorizing their probationary workers to determine those who were not mission critical, according to two new media reports citing internal sources.

129

129

Drug Topics

FEBRUARY 6, 2025

App notifications can be effected by various notification focuses, software updates, or connecting hardware, such as car audio or wireless earphones.

FDA 247

FDA 247

STAT

FEBRUARY 6, 2025

This story first appeared in Adam’s Biotech Scorecard, a subscriber-only newsletter. STAT+ subscribers can sign up  here  to get it delivered to their inbox.

127

127

Drug Topics

FEBRUARY 6, 2025

A recent study found that edible or smoked cannabis use predicted little variability in pain relief.

247

247

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

Fierce Healthcare

FEBRUARY 6, 2025

A rule barring medical debt from credit reports was set to go into effect in March, but has been caught in a regulatory freeze and indefinitely suspended under its new acting director.

114

114

Drug Topics

FEBRUARY 6, 2025

This white paper aims to delve deeper into the three pivotal strategies of driving purchasing compliancecontracts, agreements and regulations, providing insightful strategies and tools for navigating the pharmaceutical procurement process.

247

247

pharmaphorum

FEBRUARY 6, 2025

BMS is extending its bid to cut costs by $1.5bn before the end of this year, backed by 2,200 job cuts, adding a target of another $2bn by end-2027.

93

93

Fierce Healthcare

FEBRUARY 6, 2025

Cigna's Evernorth division has signed a multiyear deal with the NBA to become the official health services partner of both the NBA and the WNBA. | Cigna's Evernorth division has signed a multiyear deal with the NBA to become the official health services partner of both the NBA and the WNBA.

91

91

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.

FDA

Pharmacy Times

FEBRUARY 6, 2025

Higher p16 expression in patients with sickle cell disease led to heightened risk of age-related complications.

81

81

Fierce Healthcare

FEBRUARY 6, 2025

Eko Health developed an AI algorithm that can analyze heart sounds recorded with a digital stethoscope and identify elevated pulmonary artery systolic pressures, a key indicator of pulmonary hypertension, according to a new study.

85

85

pharmaphorum

FEBRUARY 6, 2025

Explore the clinical trends expected for 2025 - including ADCs, Radiopharmaceuticals, CGTs, AAV, and rare diseases. Stay ahead of the curve with these industry insights.

80

80

STAT

FEBRUARY 6, 2025

Y ou’re reading the web edition of STAT’s Health Tech newsletter, our guide to how technology is transforming the life sciences.  Sign up to get it  delivered in your inbox every Tuesday and Thursday. Good morning health tech readers!

79

79

Advertisement

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

Pharmacy Management Software

pharmaphorum

FEBRUARY 6, 2025

After its first phase 3 trial of obesity hope CagriSema left investors dissatisfied, Novo Nordisk has a plan to get the programme back on track.

80

80

Fierce Healthcare

FEBRUARY 6, 2025

Oscar Health put a bow on a successful 2024 with its fourth-quarter earnings call, giving updates on its ICHRA business and AI use cases. Still, earnings per share fell short of expectations.

78

78

Pharmacy Times

FEBRUARY 6, 2025

Pregnant individuals with multiple sclerosis (MS) are more likely to experience mental illness both during their pregnancy and in the first years after giving birth.

73

73

Fierce Healthcare

FEBRUARY 6, 2025

Nationwide, hospitals' outpatient revenue and below-inflation expense increases fueled a 9% year-over-year increase in 12-month operating margins, Kaufman Hall wrote in its latest monthly sector report.

Hospitals 70

Hospitals 70

STAT

FEBRUARY 6, 2025

Get your daily dose of health and medicine every weekday with STAT’s free newsletter Morning Rounds.  Sign up here. Good morning! Yesterday was a big day for the (small? huge?) Venn diagram overlap of STAT readers and One Tree Hill fans because Sophia Bush posted a link to Matt Herper’s recent story about vaccines on Instagram.

Vaccines 70

Vaccines 70

pharmaphorum

FEBRUARY 6, 2025

AstraZeneca's exposure to liability in a Chinese investigation into illegal drug imports appears to be much less than had been feared.

66

66

Pharmacy Times

FEBRUARY 6, 2025

T cells are emerging as a transformative immunotherapy approach in oncology, offering unique mechanisms for targeting hematologic and solid tumors, with clinical trials demonstrating promising survival outcomes and durable immune responses.

Immunization 65

Immunization 65

Pharmaceutical Technology

FEBRUARY 6, 2025

CagriSema, considered a successor to Wegovy, is Novo Nordisks most likely route of gaining GLP-1RA market share back from Eli Lilly.

64

64

Pharmacy Times

FEBRUARY 6, 2025

Proteolysis-targeting chimeras hold enormous potential, but also present significant challenges to drug developers.

65

65

Pharmaceutical Technology

FEBRUARY 6, 2025

The UK-based drugmaker reported a 21% increase in annual revenues, reaching 43bn ($54.1bn) in 2024.

59

59

Pharmacy Times

FEBRUARY 6, 2025

Often an indicator of fibrosis or damage to the heart, late gadolinium enhancement was found to be unaffected by the administration of intravenous immunoglobulin (IVIG) in pediatric patients with myocarditis.

65

65

Pharmaceutical Technology

FEBRUARY 6, 2025

The FDA has granted orphan drug designation (ODD) and RPDD to Arbor Biotechnologies' ABO-101, to treat primary hyperoxaluria type 1 (PH1).

FDA 59

FDA 59

Pharmacy Times

FEBRUARY 6, 2025

Dr. Reddys gets exclusive rights to commercialize the subcutaneous as well as intravenous formulations of HLX15 in the U.S.

65

65

Pharmaceutical Technology

FEBRUARY 6, 2025

EVA Pharma of Africa, DNA Script and Quantoom Biosciences have signed a MoU to establish the mRNA production platform in Egypt.

59

59

Pharmacy Times

FEBRUARY 6, 2025

Edward Kim, MD, MBA, discusses critical points of patient leakage in precision medicine, emphasizing the role of multidisciplinary teams in streamlining care, managing medications, and improving patient outcomes.

65

65